Celsion Corporation Files Provisional U.S. Patent Application for a Broad Range of Next Generation DNA Vaccines
28 janv. 2021 08h00 HE
|
Celsion CORP
The PLACCINE Platform Technology is Conceived to Enable Rapid Development of Vaccines That Can Address a Broad Range of Infectious Agents, including SARS-Associated Coronavirus (SARS-CoV) ...
WANdisco Awarded U.S. Patent for Core Active-Active Data Replication Technology
07 nov. 2012 02h00 HE
|
WANdisco, Plc.
SHEFFIELD, UNITED KINGDOM and SAN RAMON, CA--(Marketwire - Nov 7, 2012) - WANdisco (LSE: WAND), a leading provider of global collaboration software to the software development industry, announces...